Clinical Research Details Clinical Research SAGE-PsA Study Sex- And Gender-based analysis of the Effectiveness of advanced therapies in Psoriatic Arthritis Study Description The purpose of this study is to understand how sex and gender influence response to advanced therapies (also known as “biologic treatments”) in Psoriatic Arthritis (PsA). We hope to discover causes that explain why men and women with PsA respond differently to treatments. This study should take approximately 3 years to complete. You will be expected to participate for up to 1 year. Inclusion/Exclusion Criteria Inclusion criteria Patients with a rheumatologist-confirmed diagnosis of PsA who are initiating advanced therapy for peripheral musculoskeletal manifestations of PsA Exclusion criteria Unable to read or write Unable to sign informed consent Cannot return for a follow up visit The drug is given for another indication and not for active PsA (e.g. psoriasis, IBD) Pregnant women Open Enrollment Contact Name: Caroline HowardContact Phone: (904) 633-0914Contact Email: caroline.howard@jax.ufl.edu Investigators Gurjit S. Kaeley, M.B.B.S. (M.D.) Medicine